A novel biomarker associated with EBV infection improves response prediction of immunotherapy in gastric cancer.

Xiaoqin LiFen XiongZhangmin HuQing TaoYufei YangXuehan QiaoChen PengYuchun JiangMiao HanKebin DongYi HuaWei ZhangMin XuWeiguo LongYichuan XiaoDeqiang Wang

Published in: Journal of translational medicine (2024)

CHAF1A could be a novel biomarker for immunotherapy of GC, with the potential to improve the efficacy of existing biomarkers.

Keyphrases

epstein barr virus
diffuse large b cell lymphoma
mass spectrometry
risk assessment